April 2026

MIA team share learnings at two international conferences

MIA team share learnings at two international conferences

Read more about how the MIA team continues to play a leading role in advancing the frontiers of melanoma research, presenting new findings at two major international oncology conferences - the AACR Annual Meeting in San Diego, and the EADO Congress in Prague.

By MIA|2026-05-08T10:03:50+10:00April 26th, 2026|Research News|Comments Off

Streamlining assessment of pathological response after neoadjuvant treatment

Streamlining assessment of pathological response after neoadjuvant treatment

Neoadjuvant immunotherapy continues to transform outcomes for people with melanoma and other cancers. Two recent papers show that assessing pathological response after neoadjuvant immunotherapy can be both more efficient and more consistent, without compromising accuracy.